Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFragrant Prosp. Regulatory News (FPP)

Share Price Information for Fragrant Prosp. (FPP)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.00 (0.00%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £1.21m
FPP Live PriceLast checked at - London Stock Exchange

Intraday Fragrant Prosp. Share Chart

Issue of Equity

23 Apr 2025 08:54

RNS Number : 8427F
Fragrant Prosperity Holdings Ltd
23 April 2025
 

23 April 2025

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. 

 

Fragrant Prosperity Holdings Limited

("FPP" or the "Company")

Equity Fundraise

Fragrant Prosperity Holdings Limited ("Fragrant" or the "Company") announces it has completed (subject to certain conditions) an equity fundraise of £74,630.73 (gross) (the "Fundraise") through the issue of 12,438,455 ordinary shares (the "Fundraise Shares") at a price of 0.6 pence per ordinary share.

The Fundraise has been undertaken by way of a placing of new ordinary shares ("Placing") of no par value ("Ordinary Shares") in the share capital of the Company and was arranged by Optiva Securities Limited ("Optiva") with its clients. The Fundraise is to provide additional capital for the Company to pursue its investment strategy of acquiring a disruptive AI driven fintech business.

The Company is restricted in that it can only issue up to 19.99% of its issued share capital in any 12 month period without the publication of a prospectus, therefore the Fundraise Shares have been restricted to and represent 19.99% of the issued share capital of the Company prior to the Fundraise.

The Fundraise has been undertaken by means of the Placing pursuant to which, the Company will issue 12,483,455 ordinary shares at a price of 0.6p per new ordinary share ("Issue Price"), with each Ordinary Share carrying a half warrant exercisable at a rice of 0.8p per share valid for 12 months.

Admission and Total Voting Rights

Following Admission of the Fundraise Shares, which is expected to occur at 8.00 am on the 30th April 2025, the total number of Ordinary Shares in the Company will be 74,661,841. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of regulation 11 of the market abuse (amendment) (EU exit) regulations 2019/310. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

*Ends*

 

 

Fragrant Prosperity Holdings Limited

+44 (0) 20 3137 1902

Broker: Optiva Securities

Vishal Balasingham +44 (0) 20 3137 1903

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFEDSVIVFIE
Date   Source Headline
6th Apr 202111:01 amRNSPrice Monitoring Extension
29th Mar 20219:00 amRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSAppointment of Director
17th Mar 20212:05 pmRNSSecond Price Monitoring Extn
17th Mar 20212:00 pmRNSPrice Monitoring Extension
2nd Mar 202111:05 amRNSSecond Price Monitoring Extn
2nd Mar 202111:00 amRNSPrice Monitoring Extension
2nd Mar 20219:05 amRNSSecond Price Monitoring Extn
2nd Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20214:40 pmRNSSecond Price Monitoring Extn
1st Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20219:05 amRNSSecond Price Monitoring Extn
1st Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSEquity Fundraise
26th Feb 20219:06 amRNSSecond Price Monitoring Extn
26th Feb 20219:00 amRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSExpansion of investment mandate
12th Feb 20214:40 pmRNSSecond Price Monitoring Extn
12th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20214:41 pmRNSSecond Price Monitoring Extn
9th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:01 pmRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSHalf-year Report
17th Aug 20207:50 amRNSAnnual Financial Report
8th Jun 20207:50 amRNSConvertible Loan Notes and grant of Options
20th Dec 20197:00 amRNSResult of AGM
16th Dec 20197:00 amRNSIssue of Convertible Loan Notes&Change of Director
25th Nov 20198:34 amRNSHalf-year Report
21st Nov 20197:00 amRNSNotice of AGM
15th Nov 20199:23 amRNSDirectorate Change
12th Nov 20197:00 amRNSAnnual Financial Report
15th Jul 20199:20 amRNSIssue of Equity
17th Jun 20199:07 amRNSIssue of Equity
13th Jun 20199:39 amRNSDirectorate Change
14th Jan 20198:02 amRNSHalf-year Report
1st Oct 20188:57 amRNSResult of AGM
29th Aug 201810:16 amRNSNotice of AGM
21st Aug 20189:57 amRNSFinal Results
15th Aug 20187:20 amRNSHolding(s) in Company
4th Jul 20187:46 amRNSDirectorate Change
28th Mar 201810:52 amRNSDirectorate Change
15th Jan 20181:42 pmRNSHolding(s) in Company - Replacement
15th Jan 20181:40 pmRNSHolding(s) in Company
12th Jan 20182:11 pmRNSHolding(s) in Company
12th Jan 20182:10 pmRNSHolding(s) in Company
12th Jan 20182:06 pmRNSHolding(s) in Company
21st Dec 20177:00 amRNSHalf-year Report
11th Dec 20175:02 pmRNSChange of Name
31st Oct 20177:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.